Evidence map›Paper›PMID 42397500›Full record

ReviewCellular oncology (Dordrecht, Netherlands)2026

Neural regulation of cancer: from synaptic integration to neuro-immune regulation.

Xiaomeng Li, Yuxin Li, Xiaoyan Shi, Yunyun Wang, Shaoping Ji

Abstract readReview
In one paragraph

Review in Cellular oncology (Dordrecht, Netherlands), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Xiaomeng LiCenter for Molecular Medicine, Zhengzhou Health College, Zhengzhou, Henan Province, 450064, China.
Yuxin LiDepartment of Anatomy and Histology & Embryology, School of Basic Medical Sciences, Henan University, Kaifeng, Henan Province, 475000, China.
Xiaoyan ShiDepartment of Anatomy and Histology & Embryology, School of Basic Medical Sciences, Henan University, Kaifeng, Henan Province, 475000, China.
Yunyun WangDepartment of Anatomy and Histology & Embryology, School of Basic Medical Sciences, Henan University, Kaifeng, Henan Province, 475000, China. wangyun1986307@henu.edu.cn.ORCID http://orcid.org/0000-0001-8421-8370
Shaoping JiCenter for Molecular Medicine, Zhengzhou Health College, Zhengzhou, Henan Province, 450064, China. shaopingji@henu.edu.cn.ORCID http://orcid.org/0000-0003-1078-1819

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The emerging field of cancer neuroscience has reshaped our understanding of tumor biology, showing that the nervous system is an active participant in the tumor microenvironment. It modulates tumor progression through synaptic communication with cancer cells, paracrine signaling via neurotransmitters and neuropeptides, and indirect regulation of the tumor immune microenvironment. Recent discoveries have shown that neurons form synapses with brain tumors and peripheral cancers, driving tumor cell proliferation and invasion. Neurotransmitter and neuropeptide signaling activates pathways in cancer cells to promote malignancy. Furthermore, the nervous system shapes anti-tumor immunity by modulating T cells, natural killer cells, macrophages, and myeloid-derived suppressor cells, creating either an immunostimulatory or, more commonly, an immunosuppressive microenvironment that facilitates immune evasion and treatment resistance. The clinical significance of the neuro-immune-tumor axis is confirmed across multiple cancer types. Consequently, therapeutic strategies targeting neural regulation are emerging, including neurotransmitter receptor blockers, denervation techniques, neuromodulation devices, and approaches to remodel the immune landscape through neural signals. This review synthesizes how nerves regulate tumor progression via synaptic connections, neurotransmitter release, and immune modulation. We also summarize current and emerging therapeutic strategies aimed at disrupting or harnessing neuro-tumor communication. By integrating recent advances, this review aims to establish a framework for understanding neural regulation of cancer and to guide future research and clinical translation in this evolving field.

Indexed as

NeoplasmsNeuronsSynapsesAnimalsHumansNeurotransmitter AgentsTumor MicroenvironmentNeurotransmitter AgentsCancer neuroscienceNeural regulationNeuro-immune-tumor AxisSynaptic connectionsTumor microenvironment

Identifiers

PMID42397500
PMCPMC13623811

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.